CGB5 and neoplasm: Vaccination protocols or antibody-based neutralization of hCGβ markedly attenuated tumor growth in experimental models, indicating that disruption of CGB5-dependent pathways can re-invigorate antitumor immunity and enhance responsiveness to immune-checkpoint blockade (41, 46).